Biomarkers, Treatments, and Clinical Outcomes for Meningiomas and Other Skull Base Tumors

Dear Colleagues,

Skull base tumors such as meningiomas can prove challenging to diagnose and treat, with accompanying physical and socioeconomic deficits, other morbidities, and even mortality. These tumors are also understudied compared to other cancers, highlighting a need for more research. This Special Issue on the Biomarkers, Treatment, and Clinical Outcomes for Meningiomas and Skull Base Tumors is intended to highlight excellent molecular mechanism and pathophysiology research focused on (1) biomarker discovery and clinical variables associated with prognostic outcomes of meningiomas and other skull base tumors, as well as (2) identifying potential surgical, radiologic, pharmacologic, or other interventions, treatments, and treatment targets for these tumors. We welcome expert opinions, reviews, original basic science research, and all publications that focus on the molecular mechanisms or pathophysiology of skull base tumors, with the goal of progressing our understanding and the treatment of these tumors. Clinical trials and data without a basis in molecular mechanisms are discouraged from this special edition.

Prof. Dr. Michael Graner
Dr. Philip David Tatman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• skull base tumor
• meningioma
• biomarkers
• diagnosis
• prognosis
• radiology
• surgery
• pharmacotherapy
• immunology